as it has been approved without the black box warning on depression and suicidal ideation that its rival must carry. Chief executive Kevin Gorman didn’t disclose Ingrezza’s price today ...

The company is best known for its drug, Ingrezza. Ingrezza treats tardive dyskinesia and chorea associated with Huntington's disease. Both are movement disorders. But in the fourth quarter ...